Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Jennifer Giang Thu Le-Kure ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   3.7% 2.9% 6.3% 4.9% 2.0% 1.6% 8.2% 8.1%   Credit score (0-100)   54 59 37 43 68 73 30 30   Credit rating   BBB BBB BBB BBB A A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,692 2,028 1,406 1,859 2,291 2,145 0.0 0.0   EBITDA   275 507 114 250 924 852 0.0 0.0   EBIT   -0.6 146 -267 -106 559 590 0.0 0.0   Pre-tax profit (PTP)   -113.9 68.6 -348.7 -182.8 468.6 496.9 0.0 0.0   Net earnings   -91.2 53.4 -272.1 -142.7 367.2 386.7 0.0 0.0   Pre-tax profit without non-rec. items   -114 68.6 -349 -183 469 497 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,822 2,844 2,504 2,189 2,232 2,012 0.0 0.0   Shareholders equity total   679 624 352 209 576 904 758 758   Interest-bearing liabilities   2,562 2,348 2,265 2,266 1,665 1,154 0.0 0.0   Balance sheet total (assets)   3,518 3,425 3,106 2,971 2,736 2,481 758 758   Net Debt   2,562 2,346 2,258 2,251 1,660 1,135 -483 -483     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,692 2,028 1,406 1,859 2,291 2,145 0.0 0.0   Gross profit growth   -25.2% 19.9% -30.7% 32.2% 23.3% -6.4% -100.0% 0.0%   Employees   4 5 5 6 5 5 0 0   Employee growth %   0.0% 25.0% 0.0% 20.0% -16.7% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,518 3,425 3,106 2,971 2,736 2,481 758 758   Balance sheet change%   28.2% -2.7% -9.3% -4.4% -7.9% -9.3% -69.4% 0.0%   Added value   275.2 506.6 114.2 250.2 915.0 851.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   576 -380 -763 -712 -363 -523 -2,012 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 -1.0 -2.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -0.0% 7.2% -19.0% -5.7% 24.4% 27.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.1% 4.4% -8.2% -3.3% 19.6% 22.7% 0.0% 0.0%   ROI %   0.1% 4.9% -9.3% -3.8% 19.6% 20.9% 0.0% 0.0%   ROE %   -11.7% 8.2% -55.8% -50.9% 93.5% 52.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   19.4% 18.4% 11.5% 7.1% 21.4% 36.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   930.9% 463.1% 1,976.5% 899.6% 179.7% 133.3% 0.0% 0.0%   Gearing %   377.6% 376.2% 643.7% 1,083.1% 288.9% 127.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.9% 3.5% 3.6% 3.6% 4.7% 6.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.1 0.1 0.1 0.2 0.6 0.7 0.0 0.0   Current Ratio   0.1 0.1 0.1 0.2 0.5 0.7 0.0 0.0   Cash and cash equivalent   0.7 1.6 7.3 14.8 5.0 19.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,509.9 -1,546.8 -1,472.9 -1,294.8 -162.1 -70.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   69 101 23 42 183 170 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   69 101 23 42 185 170 0 0   EBIT / employee   -0 29 -53 -18 112 118 0 0   Net earnings / employee   -23 11 -54 -24 73 77 0 0